Clinical Trials on AMN in Switzerland
Total 33 results
-
University Hospital Inselspital, BerneWithdrawn
-
University Hospital Inselspital, BerneTerminatedAML, AdultSwitzerland
-
Glycostem Therapeutics BVRecruiting
-
University of BernNot yet recruitingExposure to Man-made Visible LightSwitzerland
-
University of BernActive, not recruitingExposure to Man-made Visible LightSwitzerland
-
University of BernCompletedExposure to Man-made Visible LightSwitzerland
-
University of BernCompletedExposure to Man-made Visible LightSwitzerland
-
University of BernNot yet recruitingExposure to Man-made Visible LightSwitzerland
-
University of BernCompletedExposure to Man-made Visible LightSwitzerland
-
University of BernCompletedExposure to Man-made Visible LightSwitzerland
-
University Hospital Inselspital, BerneRecruiting
-
University Hospital Inselspital, BerneWithdrawn
-
NestléCompletedMicrobiota Perturbation by an Environmental ChallengeSwitzerland
-
Biotronik AGCompletedLong Term Safety of the AMS 1.0Switzerland, Germany, Australia, Belgium, Netherlands
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingAntimicrobial Resistance (AMR)Switzerland
-
CSL BehringCompletedMultifocal Motor Neuropathy (MMN)Switzerland, Italy, United Kingdom
-
University of ZurichCompletedElective Surgery Requiring Tracheal Intubation Using an Oral Tracheal TubeSwitzerland, Poland
-
University Hospital Inselspital, BerneCompletedColitis | AML | MucositisSwitzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
Luzerner KantonsspitalCompletedInfection Rates Between Primary Wound-closure (Allgower) and Secondary Wound Healing After Removal of an External FixatorSwitzerland
-
Stichting Hemato-Oncologie voor Volwassenen NederlandSwiss Group for Clinical Cancer ResearchActive, not recruitingAML/MDSNetherlands, Belgium, Germany, Switzerland
-
University of LuganoCompletedGroup 1 (Control): Access to a Static Version of the Website Containing Only Static Features (i.e. Library, First Aid, and FAQ) | Group2 (Intervention) Access to an Interactive Version of the Website Containing Both Static and Interactive FeaturesSwitzerland
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
OncoVerity, Inc.Janssen Research & Development, LLC; argenxCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteSwitzerland, France
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Childhood Hodgkin Lymphoma | Ann Arbor Stage I Childhood Hodgkin Lymphoma | Ann Arbor Stage II Childhood Hodgkin Lymphoma | Ann Arbor Stage III Childhood Hodgkin Lymphoma | Ann Arbor Stage IV Childhood Hodgkin LymphomaUnited States, Canada, Australia, Switzerland
-
Association for Innovation and Biomedical Research...European Vision Institute Clinical Research NetworkActive, not recruitingAtrophy | Age Related Macular Degeneration | Prediction | Intermediate AMDPortugal, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
Hoffmann-La RocheTerminatedLeukemia, Myeloid, AcuteItaly, Korea, Republic of, Belgium, Australia, United States, Canada, United Kingdom, Spain, Netherlands, France, Germany, New Zealand, Israel, Norway, Russian Federation, Switzerland, Austria, Finland, Panama
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
Cogent Biosciences, Inc.RecruitingAdvanced Systemic Mastocytosis (AdvSM) | SM With an Associated Hematologic Neoplasm (SM-AHN) | Mast Cell Leukemia (MCL) | Aggressive Systemic Mastocytosis (ASM)Norway, United States, Spain, Australia, United Kingdom, Switzerland, Germany, Belgium, Netherlands, Canada, France, Austria, Italy
-
AbbVieActive, not recruitingCancer | Acute Myeloid Leukemia (AML)United States, Australia, Brazil, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Spain, Switzerland, Taiwan, United Kingdom
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia (AML)United States, Spain, Belgium, Germany, Japan, Taiwan, Turkey, Italy, Australia, Austria, Switzerland, Israel, Bulgaria, France, Norway, Brazil, Poland, Portugal, Czechia, Argentina
-
AbbVieRoche-GenentechCompletedNon-Hodgkin's Lymphoma | Neuroblastoma | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | MalignanciesUnited States, Australia, Canada, France, Germany, Netherlands, Switzerland, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Down Syndrome | Philadelphia Chromosome Positive | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia | Adult B Lymphoblastic Lymphoma | Ann Arbor Stage I B Lymphoblastic Lymphoma | Ann Arbor Stage... and other conditionsUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland